BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

808 related articles for article (PubMed ID: 31653849)

  • 1. YTHDF1 links hypoxia adaptation and non-small cell lung cancer progression.
    Shi Y; Fan S; Wu M; Zuo Z; Li X; Jiang L; Shen Q; Xu P; Zeng L; Zhou Y; Huang Y; Yang Z; Zhou J; Gao J; Zhou H; Xu S; Ji H; Shi P; Wu DD; Yang C; Chen Y
    Nat Commun; 2019 Oct; 10(1):4892. PubMed ID: 31653849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orai3 constitutes a native store-operated calcium entry that regulates non small cell lung adenocarcinoma cell proliferation.
    Ay AS; Benzerdjeb N; Sevestre H; Ahidouch A; Ouadid-Ahidouch H
    PLoS One; 2013; 8(9):e72889. PubMed ID: 24058448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. piR-651 promotes tumor formation in non-small cell lung carcinoma through the upregulation of cyclin D1 and CDK4.
    Li D; Luo Y; Gao Y; Yang Y; Wang Y; Xu Y; Tan S; Zhang Y; Duan J; Yang Y
    Int J Mol Med; 2016 Sep; 38(3):927-36. PubMed ID: 27431575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homeobox Transcription Factor NKX2-1 Promotes
    Harada M; Sakai S; Ohhata T; Kitagawa K; Mikamo M; Nishimoto K; Uchida C; Niida H; Kotake Y; Sugimura H; Suda T; Kitagawa M
    Mol Cancer Res; 2017 Oct; 15(10):1388-1397. PubMed ID: 28634225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loading MicroRNA-376c in Extracellular Vesicles Inhibits Properties of Non-Small Cell Lung Cancer Cells by Targeting YTHDF1.
    Zhou J; Xiao D; Qiu T; Li J; Liu Z
    Technol Cancer Res Treat; 2020; 19():1533033820977525. PubMed ID: 33280517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. YTHDF1 Promotes Cyclin B1 Translation through m
    Lou X; Ning J; Liu W; Li K; Qian B; Xu D; Wu Y; Zhang D; Cui W
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The transcription factor DEC1 (BHLHE40/STRA13/SHARP-2) is negatively associated with TNM stage in non-small-cell lung cancer and inhibits the proliferation through cyclin D1 in A549 and BE1 cells.
    Liu Y; Wang L; Lin XY; Wang J; Yu JH; Miao Y; Wang EH
    Tumour Biol; 2013 Jun; 34(3):1641-50. PubMed ID: 23423709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circular RNA circ-CMPK1 contributes to cell proliferation of non-small cell lung cancer by elevating cyclin D1 via sponging miR-302e.
    Cui D; Qian R; Li Y
    Mol Genet Genomic Med; 2020 Feb; 8(2):e999. PubMed ID: 31863641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of tripartite motif containing 26 inhibits non-small cell lung cancer cell growth by suppressing PI3K/AKT signaling.
    Tao JL; Luo M; Sun H; Zhao HM; Sun QS; Huang ZM
    Kaohsiung J Med Sci; 2020 Jun; 36(6):417-422. PubMed ID: 32052576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. m
    Jin D; Guo J; Wu Y; Yang L; Wang X; Du J; Dai J; Chen W; Gong K; Miao S; Li X; Sun H
    Mol Cancer; 2020 Feb; 19(1):40. PubMed ID: 32106857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. METTL3 promotes non-small cell lung cancer (NSCLC) cell proliferation and colony formation in a m6A-YTHDF1 dependent way.
    Dou X; Wang Z; Lu W; Miao L; Zhao Y
    BMC Pulm Med; 2022 Aug; 22(1):324. PubMed ID: 36008805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-31/QKI-5 axis facilitates cell cycle progression of non-small-cell lung cancer cells by interacting and regulating p21 and CDK4/6 expressions.
    Zhu W; Yu Y; Fang K; Xiao S; Ni L; Yin C; Huang X; Wang X; Zhang Y; Le HB; Cui R
    Cancer Med; 2023 Feb; 12(4):4590-4604. PubMed ID: 36172919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aryl hydrocarbon receptor is a target of 17-Allylamino-17-demethoxygeldanamycin and enhances its anticancer activity in lung adenocarcinoma cells.
    Chen PH; Chang JT; Li LA; Tsai HT; Shen MY; Lin P
    Mol Pharmacol; 2013 Mar; 83(3):605-12. PubMed ID: 23229511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of TMPRSS4 in non-small cell lung cancer and its modulation by hypoxia.
    Nguyen TH; Weber W; Havari E; Connors T; Bagley RG; McLaren R; Nambiar PR; Madden SL; Teicher BA; Roberts B; Kaplan J; Shankara S
    Int J Oncol; 2012 Sep; 41(3):829-38. PubMed ID: 22692880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. m
    Jin D; Guo J; Wu Y; Du J; Yang L; Wang X; Di W; Hu B; An J; Kong L; Pan L; Su G
    J Hematol Oncol; 2019 Dec; 12(1):135. PubMed ID: 31818312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Twist may be associated with invasion and metastasis of hypoxic NSCLC cells.
    Wei L; Sun JJ; Cui YC; Jiang SL; Wang XW; Lv LY; Xie L; Song XR
    Tumour Biol; 2016 Jul; 37(7):9979-87. PubMed ID: 26819207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of STIM1 expression inhibits non-small-cell lung cancer cell proliferation
    Ge C; Zeng B; Li R; Li Z; Fu Q; Wang W; Wang Z; Dong S; Lai Z; Wang Y; Xue Y; Guo J; Di T; Song X
    Bioengineered; 2019 Dec; 10(1):425-436. PubMed ID: 31564210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolutionary selected Tibetan variants of HIF pathway and risk of lung cancer.
    Lanikova L; Reading NS; Hu H; Tashi T; Burjanivova T; Shestakova A; Siwakoti B; Thakur BK; Pun CB; Sapkota A; Abdelaziz S; Feng BJ; Huff CD; Hashibe M; Prchal JT
    Oncotarget; 2017 Feb; 8(7):11739-11747. PubMed ID: 28036300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analysis of long noncoding RNA and mRNA expression provides insights into adaptation to hypoxia in Tibetan sheep.
    Wang F; Liu J; Zeng Q; Zhuoga D
    Sci Rep; 2022 Apr; 12(1):6597. PubMed ID: 35449433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of lncRNA-BLACAT1 on drug resistance of non-small cell lung cancer cells in DDP chemotherapy by regulating cyclin D1 expression.
    Ju ZS; Sun B; Bao D; Zhang XF
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9465-9472. PubMed ID: 33015788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.